Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Apr 1;347(Pt 1):131–138.

Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE).

J Schlöndorff 1, J D Becherer 1, C P Blobel 1
PMCID: PMC1220940  PMID: 10727411

Abstract

Tumour necrosis factor alpha convertase (TACE) is a metalloprotease/disintegrin involved in the ectodomain shedding of several proteins, a process thought to be important in inflammation, rheumatoid arthritis and murine development. The characterization of the intracellular maturation and subcellular localization of endogenous TACE is decribed in the present study. Similarly to other proteolytically active metalloprotease/disintegrins, two forms of TACE are found in cells; a full-length precursor and a mature form lacking the prodomain. Prodomain removal occurs in a late Golgi compartment, consistent with the proposed role of a furin type proprotein convertase in this process. An additional form of TACE, lacking the pro and cytoplasmic domains, is detected when cell lysates are prepared in the presence of EDTA instead of a hydroxamate-based metalloprotease inhibitor or 1,10-phenanthroline. This form appears to be generated by mature TACE cleaving its own cytoplasmic tail and may explain why little mature TACE has been detected in previous studies. In cell-surface labelling experiments, mature TACE was detected on the cell surface but immunofluorescence data indicate that TACE is predominantly localized to a perinuclear compartment similar to that described for tumour necrosis factor (TNF)alpha. This raises the possibility that TACE-mediated ectodomain shedding may occur in an intracellular compartment in addition to the cell surface.

Full Text

The Full Text of this article is available as a PDF (235.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arribas J., Coodly L., Vollmer P., Kishimoto T. K., Rose-John S., Massagué J. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem. 1996 May 10;271(19):11376–11382. doi: 10.1074/jbc.271.19.11376. [DOI] [PubMed] [Google Scholar]
  2. Arribas J., Massagué J. Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J Cell Biol. 1995 Feb;128(3):433–441. doi: 10.1083/jcb.128.3.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Black R. A., Rauch C. T., Kozlosky C. J., Peschon J. J., Slack J. L., Wolfson M. F., Castner B. J., Stocking K. L., Reddy P., Srinivasan S. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997 Feb 20;385(6618):729–733. doi: 10.1038/385729a0. [DOI] [PubMed] [Google Scholar]
  4. Black R. A., White J. M. ADAMs: focus on the protease domain. Curr Opin Cell Biol. 1998 Oct;10(5):654–659. doi: 10.1016/s0955-0674(98)80042-2. [DOI] [PubMed] [Google Scholar]
  5. Blobel C. P., Myles D. G., Primakoff P., White J. M. Proteolytic processing of a protein involved in sperm-egg fusion correlates with acquisition of fertilization competence. J Cell Biol. 1990 Jul;111(1):69–78. doi: 10.1083/jcb.111.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buxbaum J. D., Liu K. N., Luo Y., Slack J. L., Stocking K. L., Peschon J. J., Johnson R. S., Castner B. J., Cerretti D. P., Black R. A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem. 1998 Oct 23;273(43):27765–27767. doi: 10.1074/jbc.273.43.27765. [DOI] [PubMed] [Google Scholar]
  7. Dallas D. J., Genever P. G., Patton A. J., Millichip M. I., McKie N., Skerry T. M. Localization of ADAM10 and Notch receptors in bone. Bone. 1999 Jul;25(1):9–15. doi: 10.1016/s8756-3282(99)00099-x. [DOI] [PubMed] [Google Scholar]
  8. Krätzschmar J., Lum L., Blobel C. P. Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence. J Biol Chem. 1996 Mar 1;271(9):4593–4596. doi: 10.1074/jbc.271.9.4593. [DOI] [PubMed] [Google Scholar]
  9. Loechel F., Gilpin B. J., Engvall E., Albrechtsen R., Wewer U. M. Human ADAM 12 (meltrin alpha) is an active metalloprotease. J Biol Chem. 1998 Jul 3;273(27):16993–16997. doi: 10.1074/jbc.273.27.16993. [DOI] [PubMed] [Google Scholar]
  10. Loechel F., Overgaard M. T., Oxvig C., Albrechtsen R., Wewer U. M. Regulation of human ADAM 12 protease by the prodomain. Evidence for a functional cysteine switch. J Biol Chem. 1999 May 7;274(19):13427–13433. doi: 10.1074/jbc.274.19.13427. [DOI] [PubMed] [Google Scholar]
  11. Lum L., Reid M. S., Blobel C. P. Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J Biol Chem. 1998 Oct 2;273(40):26236–26247. doi: 10.1074/jbc.273.40.26236. [DOI] [PubMed] [Google Scholar]
  12. Lum L., Wong B. R., Josien R., Becherer J. D., Erdjument-Bromage H., Schlöndorff J., Tempst P., Choi Y., Blobel C. P. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem. 1999 May 7;274(19):13613–13618. doi: 10.1074/jbc.274.19.13613. [DOI] [PubMed] [Google Scholar]
  13. McGeehan G. M., Becherer J. D., Bast R. C., Jr, Boyer C. M., Champion B., Connolly K. M., Conway J. G., Furdon P., Karp S., Kidao S. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature. 1994 Aug 18;370(6490):558–561. doi: 10.1038/370558a0. [DOI] [PubMed] [Google Scholar]
  14. Merlos-Suárez A., Fernández-Larrea J., Reddy P., Baselga J., Arribas J. Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing. J Biol Chem. 1998 Sep 18;273(38):24955–24962. doi: 10.1074/jbc.273.38.24955. [DOI] [PubMed] [Google Scholar]
  15. Milla M. E., Leesnitzer M. A., Moss M. L., Clay W. C., Carter H. L., Miller A. B., Su J. L., Lambert M. H., Willard D. H., Sheeley D. M. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J Biol Chem. 1999 Oct 22;274(43):30563–30570. doi: 10.1074/jbc.274.43.30563. [DOI] [PubMed] [Google Scholar]
  16. Moss M. L., Jin S. L., Milla M. E., Bickett D. M., Burkhart W., Carter H. L., Chen W. J., Clay W. C., Didsbury J. R., Hassler D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 1997 Feb 20;385(6618):733–736. doi: 10.1038/385733a0. [DOI] [PubMed] [Google Scholar]
  17. Nelson K. K., Schlöndorff J., Blobel C. P. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. Biochem J. 1999 Nov 1;343(Pt 3):673–680. [PMC free article] [PubMed] [Google Scholar]
  18. Nemunaitis J., Poole C., Primrose J., Rosemurgy A., Malfetano J., Brown P., Berrington A., Cornish A., Lynch K., Rasmussen H. Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. Clin Cancer Res. 1998 May;4(5):1101–1109. [PubMed] [Google Scholar]
  19. Peschon J. J., Slack J. L., Reddy P., Stocking K. L., Sunnarborg S. W., Lee D. C., Russell W. E., Castner B. J., Johnson R. S., Fitzner J. N. An essential role for ectodomain shedding in mammalian development. Science. 1998 Nov 13;282(5392):1281–1284. doi: 10.1126/science.282.5392.1281. [DOI] [PubMed] [Google Scholar]
  20. Primakoff P., Myles D. G. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 2000 Feb;16(2):83–87. doi: 10.1016/s0168-9525(99)01926-5. [DOI] [PubMed] [Google Scholar]
  21. Roghani M., Becherer J. D., Moss M. L., Atherton R. E., Erdjument-Bromage H., Arribas J., Blackburn R. K., Weskamp G., Tempst P., Blobel C. P. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem. 1999 Feb 5;274(6):3531–3540. doi: 10.1074/jbc.274.6.3531. [DOI] [PubMed] [Google Scholar]
  22. Sadhukhan R., Santhamma K. R., Reddy P., Peschon J. J., Black R. A., Sen I. Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor necrosis factor-alpha-converting enzyme-deficient mice. J Biol Chem. 1999 Apr 9;274(15):10511–10516. doi: 10.1074/jbc.274.15.10511. [DOI] [PubMed] [Google Scholar]
  23. Schlöndorff J., Blobel C. P. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J Cell Sci. 1999 Nov;112(Pt 21):3603–3617. doi: 10.1242/jcs.112.21.3603. [DOI] [PubMed] [Google Scholar]
  24. Solomon K. A., Covington M. B., DeCicco C. P., Newton R. C. The fate of pro-TNF-alpha following inhibition of metalloprotease-dependent processing to soluble TNF-alpha in human monocytes. J Immunol. 1997 Nov 1;159(9):4524–4531. [PubMed] [Google Scholar]
  25. Van Wart H. E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578–5582. doi: 10.1073/pnas.87.14.5578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van't Hof W., Resh M. D. Rapid plasma membrane anchoring of newly synthesized p59fyn: selective requirement for NH2-terminal myristoylation and palmitoylation at cysteine-3. J Cell Biol. 1997 Mar 10;136(5):1023–1035. doi: 10.1083/jcb.136.5.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES